Sai Parenteral's Limited Share Price & Stock Analysis

Sai Parenteral's Limited (NSE: SAIPARENT, BSE: 544742) is a Hyderabad, Telangana-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹2,235 Cr, it ranks #1,193 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹506.40 (as of 16 Nov 2026), the share price is 28.3% below its 52-week high of ₹706.00 and 26.6% above its 52-week low of ₹400.00.

Key Metrics

Current Price₹506.40
Market Cap₹2,235 Cr
NSE SymbolSAIPARENT
BSE Code544742
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio115.8
Return on Equity2.88%
Return on Assets1.97%
52-Week Range₹400.00 – ₹706.00
3-Month Price Change-11.8%
Beta (1Y)0.6
HeadquartersHyderabad, Telangana
Websitewww.saiparenterals.com

Latest Quarterly Results — Q2 FY27

Revenue₹195 Cr
Net Profit₹11 Cr
Net Margin5.4%
EPS (Basic)₹2.38
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Sai Parenteral's Limited Quarterly Revenue and Profit Trend

Sai Parenteral's Limited reported revenue of ₹195 Cr in Q2 FY27, up 9.1% from ₹179 Cr in Q1 FY27. It posted a net profit of ₹11 Cr for the quarter, against a net profit of ₹8 Cr in Q1 FY27 (up 32.7%). Across the 4 quarters from Q3 FY26 to Q2 FY27, quarterly revenue ranged from ₹96 Cr (Q3 FY26) to ₹198 Cr (Q4 FY26). The company reported a net loss in 1 of these 4 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹195 Cr₹11 Cr5.4%
Q1 FY27₹179 Cr₹8 Cr4.4%
Q4 FY26₹198 Cr₹13 Cr6.6%
Q3 FY26₹96 Cr−₹7 Cr−6.9%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 51.16% of Sai Parenteral's Limited's shares as of Sept 2026, unchanged from Mar 2026. Delivery averaged 50.8% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Sai Parenteral's Limited

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company was founded in 1988 and is based in Hyderabad, India.

Products and Services

1. Branded Generic Formulations-This segment manufactures and sell generic formulations pharmaceutical products. 2. CDMO Products and Services-This segment engages in designing and developing pharmaceutical products, validation batches, such as trial runs conducted to ensure consistent manufacturing quality, stability studies, which assess drug performance under various conditions, dossier compilation, which involves preparing and compiling documents required for product approvals. 3. NA-NA 4. NA-NA

Business Segments

1. Branded Generic Formulations-37% 2. CDMO Products and Services-63%

Sai Parenteral's Limited vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Infinium Pharmachem Limited₹436 Cr36.410.54%—+11.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sai Parenteral's Limited?

Sai Parenteral's Limited is trading at ₹506.40, with a market capitalisation of ₹2,235 Cr.

Which sector does Sai Parenteral's Limited belong to?

Sai Parenteral's Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Sai Parenteral's Limited?

Sai Parenteral's Limited has a P/E of 115.8 and a return on equity of 2.88%.

What is the stock symbol of Sai Parenteral's Limited?

Sai Parenteral's Limited is listed on the NSE under the symbol SAIPARENT and on the BSE under the scrip code 544742.

What were Sai Parenteral's Limited's latest quarterly results?

In Q2 FY27, Sai Parenteral's Limited reported revenue of ₹195 Cr and net profit of ₹11 Cr, with basic EPS of ₹2.38 (consolidated, parsed from the company's exchange filing).

What is the promoter holding in Sai Parenteral's Limited?

Promoters held 51.16% of Sai Parenteral's Limited's shares as of Sept 2026, unchanged from Mar 2026.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.